Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280198
Max Phase: Preclinical
Molecular Formula: C32H38O15
Molecular Weight: 662.64
Associated Items:
ID: ALA5280198
Max Phase: Preclinical
Molecular Formula: C32H38O15
Molecular Weight: 662.64
Associated Items:
Canonical SMILES: CC(C)=CCc1c(O)cc(O)c2c(=O)c(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(-c3ccc(O)cc3)oc12
Standard InChI: InChI=1S/C32H38O15/c1-12(2)4-9-16-17(35)10-18(36)20-23(39)29(27(45-28(16)20)14-5-7-15(34)8-6-14)46-32-30(25(41)21(37)13(3)43-32)47-31-26(42)24(40)22(38)19(11-33)44-31/h4-8,10,13,19,21-22,24-26,30-38,40-42H,9,11H2,1-3H3/t13-,19+,21-,22+,24-,25+,26+,30+,31-,32-/m0/s1
Standard InChI Key: FWINXQRXURMYOG-RTXMGSRZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 662.64 | Molecular Weight (Monoisotopic): 662.2211 | AlogP: 0.12 | #Rotatable Bonds: 8 |
Polar Surface Area: 249.20 | Molecular Species: ACID | HBA: 15 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 6.21 | CX Basic pKa: | CX LogP: 1.16 | CX LogD: -0.14 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.15 | Np Likeness Score: 2.38 |
1. Bi Y, Wang X, Han L, Tian Y, Bo T, Li C, Shi B, Gui C, Zhang Y.. (2023) Selective Inhibition of Organic Cation Transporter 1 by Benzoylpaeoniflorin Attenuates Hepatic Lipid Accumulation through AMPK Activation., 86 (1.0): [PMID:36563333] [10.1021/acs.jnatprod.2c00927] |
Source(1):